Selinexor with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments

  • Technology appraisal guidance
  • TA970
  • Published: 

History

Documents created during the development process.

Declaration of interests

Final draft guidance

Invitation to participate